LIGAND PHARMACEUTICALS INC — Director's Dealing 2016

Dec 30, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LIGAND PHARMACEUTICALS INC (LGND)
CIK: 0000886163
Period of Report: 2016-12-28

Reporting Person: Davis Todd C (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-12-28	Common Stock	G	48	$0.0	Disposed	70141	Direct

Footnotes

F1: Charitable gift to a third party.